We are live on ! Find out more
ALT icon

Altimmune

118 hedge funds and large institutions have $375M invested in Altimmune in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 30 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more call options, than puts

Call options by funds: $27.5M | Put options by funds: $7.92M

67% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 15

60% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 30

39% more capital invested

Capital invested by funds: $269M → $375M (+$106M)

11.69% more ownership

Funds ownership: 70.98%82.66% (+12%)

8% more funds holding

Funds holding: 109118 (+9)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
118
Holders Change
+9
Holders Change %
+8.26%
% of All Funds
2.07%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
25
Increased
48
Reduced
30
Closed
15
Calls
$27.5M
Puts
$7.92M
Net Calls
+$19.6M
Net Calls Change
+$20.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Simplex Trading
126
Simplex Trading
Illinois
-$84.9K -6,985 Closed
GRP
127
Global Retirement Partners
California
-$43K -4,362 Closed
SM
128
SG3 Management
Puerto Rico
-$36.5K -3,000 Closed
IA
129
IFP Advisors
Florida
-$20K -2,227 Closed
PAM
130
Panagora Asset Management
Massachusetts
-$1K -122 Closed
HI
131
Harbour Investments
Wisconsin
+$12 +1 +50%
EI
132
Ellevest Inc
New York
+$61 +5 New

ALT Hedge Fund Activity: Q3 2021 in Review

118 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q3 2021, worth a combined $375M — up 39% from $269M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ALT positions and 15 closed out — a net gain of 10 holders — while 48 added to existing stakes and 30 trimmed.

The largest buyer was Avidity Partners Management, opening a new position worth an estimated $26.4M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $15.4M sold.

  • 118 institutional investors held Altimmune (ALT) as of Q3 2021, up from 109 in Q2 2021.
  • Funds reported $375M of Altimmune stock for Q3 2021, up 39% quarter-over-quarter.
  • 25 funds opened new Altimmune positions in Q3 2021 and 15 closed out, a net change of +10 holders.
  • The largest Altimmune buyer in Q3 2021 was Avidity Partners Management, an estimated $26.4M added.
  • The largest Altimmune seller in Q3 2021 was Point72 Asset Management, an estimated $15.4M sold.

Based on aggregated 13F filings for Q3 2021.